Contact your provider immediately if you experience severe abdominal pain, persistent vomiting, signs of kidney problems, or significant changes in health status
MacMillan, S., Hosgood, S
Available from [Accessed 17 Dec 2023] Eli Lilly and Company 2023
The risk is dose-dependent and increases with prolonged use, advanced age, concurrent corticosteroid or anticoagulant use, and history of peptic ulcer disease
At least three other states California, New Hampshire and North Carolina have recently limited or plan to throttle access to GLP-1s for weight-loss, according to health policy think tank KFF
Onset and offset of therapeutic effects are directly related to the drug's half-life